Skip to main content

WHAT WE'RE LOOKING AT

High-cost mutual funds: How have they performed in the past several years?

OUR SCREEN

Story continues below advertisement

Widely available funds in all categories with assets of more than $50-million were ranked from highest management expense ratio on down, along with their quartile rankings for the one-, three- and five-year periods to March 31. Quartiles divide funds in a category into four groups, with the first quartile representing top performers and the fourth quartile indicating worst-in-class results.

WHAT WE FOUND

Costs are among the most important factors in choosing a mutual fund. Managers have good years and bad, and even the best of them tend to move on after a period with a firm. Low costs are the one thing you can count on from one year to the next. That said, it's clear from our screen that high fees do not automatically condemn you to terrible returns.

Take a look at AGF Emerging Markets - it's one of the most widely held funds in this screen, with assets of close to $1-billion, and its management expense ratio is a rotund 2.98 per cent. It's hard to complain about the returns, though. They're first or second quartile across the board.

Still, there's a high incidence of disappointing returns from these high-fee funds. Over the past five years, 12 of the top 24 funds on our list have five-year returns that rank in the third or fourth quartile. High fees have weighed even more heavily in the past 12 months, a period in which 16 of the 24 highest-cost funds ranked in the bottom two quartiles.

High fees are common in specialty areas like emerging markets and China equity, where returns can be high enough to make investors indifferent to the cost of owning a fund. Ignoring fees is a mistake, though. For every Renaissance China Plus (high cost, but first quartile for the past one-, three- and five-year periods), there's a Renaissance Global Health Care (high cost and third and fourth quartile all the way).

Report an error Editorial code of conduct Licensing Options
As of December 20, 2017, we have temporarily removed commenting from our articles. We hope to have this resolved by the end of January 2018. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.